Related Experiment Videos

Nucleotide sequence of the macromomycin apoprotein gene and its expression in Streptomyces macromomyceticus

N Sakata1, T Kanbe, M Tanabe

  • 1Showa College of Pharmaceutical Sciences, Tokyo, Japan.

Insights

Researchers sequenced the macromomycin (MCM) apoprotein gene from Streptomyces macromomyceticus, identifying its promoter, terminator, and coding sequence. Gene expression is constitutive, but holo-MCM production is condition-dependent.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Macromomycin (MCM) is an antibiotic produced by Streptomyces macromomyceticus.
  • Understanding the genetic basis of MCM production is crucial for its biotechnological applications.

Purpose of the Study:

  • To sequence the macromomycin (MCM) apoprotein gene from Streptomyces macromomyceticus.
  • To characterize the gene's regulatory elements and expression patterns.

Main Methods:

  • DNA sequencing of a 1.6 kb fragment containing the putative MCM apoprotein gene.
  • Northern blot analysis to identify mRNA transcripts.
  • Primer extension to determine the transcriptional start site.
  • Dot blot analysis to assess gene expression.

Main Results:

  • A 1,556 bp DNA fragment contained a promoter, an open reading frame (ORF) for pre-apoprotein, and a terminator.
  • The deduced amino acid sequence largely matched previously determined data, with a noted discrepancy in one residue.
  • A low GC-rich region upstream of the ORF exhibited promoter activity.
  • A ~700 nucleotide mRNA transcript was identified, and the transcriptional start site was mapped.
  • The MCM apoprotein gene is expressed constitutively, but holo-MCM production is influenced by culture conditions.

Conclusions:

  • The complete gene structure and regulatory regions of the MCM apoprotein have been elucidated.
  • Constitutive expression of the MCM apoprotein gene suggests post-transcriptional regulation of holo-MCM production.

Related Concept Videos